Funding Opportunity

Funding Opportunity - page 2

Showing 13–24 of 263 funding opportunities · Page 2 of 22

Funding Opportunity: ETHICAL, LEGAL AND SOCIAL IMPLICATIONS (ELSI) EXPLORATORY/DEVELOPMENTAL RESEARCH GRANT (R21 CLINICAL TRIAL OPTIONAL)

Read more: ETHICAL, LEGAL AND SOCIAL IMPLICATIONS (ELSI) EXPLORATORY/DEVELOPMENTAL RESEARCH GRANT (R21 CLINICAL TRIAL OPTIONAL)

GENERAL RESEARCH GRANT

Maximum Budget (USD): $125,000 per year for 1 or 2 years - Saturday, August 15, 2026 (Letter of Intent); Thursday, October 15, 2026 (Application)

Friedreich's Ataxia Research Alliance (FARA)
The General Research Grant is open to qualified investigators proposing projects that align with FARA Research Priorities.

Funding Opportunity: GENERAL RESEARCH GRANT

Read more: GENERAL RESEARCH GRANT

QUARTERLY RESEARCH GRANT FUNDING PROGRAMME

For preclinical research, grants up to £250,000 (GBP) are funded and priority is given to projects that are likely to lead to clinical trials in people with Parkinson’s within 5 years. - Monday, April 13, 2026, Monday, June 22, 2026 and Monday, October 12, 2026

Cure Parkinson's
This programme primarily funds preclinical and clinical research focused on slowing, stopping, or reversing Parkinson’s.

Funding Opportunity: QUARTERLY RESEARCH GRANT FUNDING PROGRAMME

Read more: QUARTERLY RESEARCH GRANT FUNDING PROGRAMME

Funding Opportunity: CLINICAL CHARACTERIZATION OF CANCER THERAPY-INDUCED ADVERSE SEQUELAE AND MECHANISM-BASED INTERVENTIONAL STRATEGIES (R01 CLINICAL TRIAL OPTIONAL)

Read more: CLINICAL CHARACTERIZATION OF CANCER THERAPY-INDUCED ADVERSE SEQUELAE AND MECHANISM-BASED INTERVENTIONAL STRATEGIES (R01 CLINICAL TRIAL OPTIONAL)

Funding Opportunity: NCI Investigator-Initiated Early Phase Cancer Clinical Trials (R01, Clinical Trial Required)

Read more: NCI Investigator-Initiated Early Phase Cancer Clinical Trials (R01, Clinical Trial Required)

Funding Opportunity: CANCER PREVENTION AND CONTROL CLINICAL TRIALS GRANT PROGRAM (R01 CLINICAL TRIAL REQUIRED)

Read more: CANCER PREVENTION AND CONTROL CLINICAL TRIALS GRANT PROGRAM (R01 CLINICAL TRIAL REQUIRED)

NCSBN GRANT PROGRAM

Up to $300,000 - Friday, October 02, 2026

National Council of State Boards of Nursing (NCSBN)
The NCSBN Grant Program provides funding for scientific research projects that advance the science of nursing policy and regulation and build regulatory expertise worldwide.

Funding Opportunity: NCSBN GRANT PROGRAM

Read more: NCSBN GRANT PROGRAM

PROJECT SUPPORT

$50,000 - Thursday, October 01, 2026

Laerdal Foundation
This supports applications that relate to factors 2 and 3 of the Utstein Formula for Survival.

Funding Opportunity: PROJECT SUPPORT

Read more: PROJECT SUPPORT

Funding Opportunity: SAVING LIVES AT BIRTH IN LOW-RESOURCE SETTINGS GRANTS

Read more: SAVING LIVES AT BIRTH IN LOW-RESOURCE SETTINGS GRANTS

Funding Opportunity: PROGRAM SUPPORT: ADVANCING GLOBAL CARDIAC AND MATERNAL HEALTH

Read more: PROGRAM SUPPORT: ADVANCING GLOBAL CARDIAC AND MATERNAL HEALTH

RESEARCH GRANTS FOR Morton Cure Paralysis

From $5,000 to $75,000 - Wednesday, September 30, 2026

MORTON CURE PARALYSIS FUND - MCPF
The Morton Cure Paralysis Fund (MCPF) iMCPF funds promising research aimed at developing therapies for paralysis, with a focus on helping scientists generate proof-of-concept data needed for larger NIH grants.

Funding Opportunity: RESEARCH GRANTS FOR Morton Cure Paralysis

Read more: RESEARCH GRANTS FOR Morton Cure Paralysis

PITT HOPKINS SYNDROME GRANTS

$75,000 - No deadline

PiTT HOPKINS RESEARCH FOUNDATION
The mission of the Pitt Hopkins Research Foundation (PHRF) is to support research dedicated to finding a treatment, and an eventual cure for Pitt Hopkins Syndrome and other similar disorders.

Funding Opportunity: PITT HOPKINS SYNDROME GRANTS

Read more: PITT HOPKINS SYNDROME GRANTS